We just received data on a new analyst forecast for $STZ. Wells Fargo gave a rating of 'Overweight' for $STZ.
$STZ Analyst Ratings
Wall Street analysts have issued reports on $STZ in the last several months. We have seen 11 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 09/25/2025
- Bernstein issued a "Outperform" rating on 09/04/2025
- Needham issued a "Buy" rating on 09/03/2025
- Jefferies issued a "Buy" rating on 09/03/2025
- Goldman Sachs issued a "Buy" rating on 09/03/2025
- B of A Securities issued a "Underperform" rating on 09/03/2025
- Roth Capital issued a "Buy" rating on 09/03/2025
To track analyst ratings and price targets for $STZ, check out Quiver Quantitative's $STZ forecast page.
$STZ Price Targets
Multiple analysts have issued price targets for $STZ recently. We have seen 17 analysts offer price targets for $STZ in the last 6 months, with a median target of $180.0.
Here are some recent targets:
- Chris Carey from Wells Fargo set a target price of $155.0 on 09/25/2025
- Filippo Falorni from Citigroup set a target price of $145.0 on 09/23/2025
- Lauren Lieberman from Barclays set a target price of $150.0 on 09/12/2025
- Robert Moskow from TD Cowen set a target price of $152.0 on 09/04/2025
- Nadine Sarwat from Bernstein set a target price of $195.0 on 09/04/2025
- Andrew Strelzik from BMO Capital set a target price of $190.0 on 09/04/2025
- Kaumil Gajrawala from Jefferies set a target price of $179.0 on 09/03/2025
$STZ Congressional Stock Trading
Members of Congress have traded $STZ stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $STZ stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/17.
- SENATOR TOMMY TUBERVILLE sold up to $50,000 on 04/15.
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 04/08.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/01.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$STZ Insider Trading Activity
$STZ insiders have traded $STZ stock on the open market 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $STZ stock by insiders over the last 6 months:
- SAMUEL J GLAETZER (EVP & Pres. Wine and Spirits) sold 3,150 shares for an estimated $593,901
- CHRISTOPHER J BALDWIN has made 2 purchases buying 2,000 shares for an estimated $340,886 and 0 sales.
- JAMES O. BOURDEAU (EVP & Chief Legal Officer) sold 821 shares for an estimated $138,749
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$STZ Hedge Fund Activity
We have seen 477 institutional investors add shares of $STZ stock to their portfolio, and 873 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALLIANCEBERNSTEIN L.P. removed 1,769,201 shares (-91.2%) from their portfolio in Q2 2025, for an estimated $287,813,618
- AMERIPRISE FINANCIAL INC added 1,533,961 shares (+650.6%) to their portfolio in Q2 2025, for an estimated $249,544,775
- D1 CAPITAL PARTNERS L.P. removed 1,527,689 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $280,361,485
- BERKSHIRE HATHAWAY INC added 1,391,000 shares (+11.6%) to their portfolio in Q2 2025, for an estimated $226,287,880
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,338,076 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $245,563,707
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC added 1,312,910 shares (+inf%) to their portfolio in Q2 2025, for an estimated $213,584,198
- DARSANA CAPITAL PARTNERS LP removed 1,250,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $229,400,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.